Anzeige
Mehr »
Login
Dienstag, 05.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Sagenhafte +10.000 % Gewinnchance mit Spezialisten für KI-Cybersecurity!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
351 Leser
Artikel bewerten:
(2)

FnF Research: USD 20.34 Billion Growth in Cardiovascular Devices Market Size - Industry Analysis, Market Trends, Market Growth, Opportunities, Comprehensive Research Report [2023-2030]

NEW YORK, May 17, 2023 /PRNewswire/ -- As per Facts and Factors study, the global cardiovascular devices market size is valued at USD 5.8 billion in 2022 and is expected to reach USD 20.34 billion during the forecast period. The market is expected to grow at a compound annual rate of 13% during 2023-2030.

FnF_Research_Logo

Report Link with All Related Graphs & Charts: https://www.fnfresearch.com/cardiovascular-devices-market

Cardiovascular Devices Market: Overview

Cardiovascular devices are medical-grade instruments used to diagnose and treat heart disease and other associated problems. These devices include angioplasty balloon catheters, endovascular grafts, coronary stents, and artificial heart valves. These devices are of immense importance because these instruments save millions of lives each year.

However, the manufacturing and designing of cardiovascular devices are complex. It takes more precision, investment, and research studies to successfully produce these medical instruments.

Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.fnfresearch.com/sample/cardiovascular-devices-market

Key Insights:

  • As per the analysis shared by our research analyst, the global cardiovascular devices market is estimated to grow annually at a CAGR of around 13% over the forecast period (2023-2030).
  • In terms of revenue, the global market size was valued at around USD 5.8 billion in 2022 and is projected to reach USD 20.34 billion by 2030.
  • The rising prevalence of cardiovascular disease is likely to boost the gamification market growth.
  • Based on the device type, the diagnostic & monitoring devices segment is the fastest-growing segment in the global market.
  • Based on the end users, the hospital segment accounts for the largest share of the global market.
  • Based on the applications, the heart failure segment is likely to dominate the global market.
  • Based on region, Asia Pacific is expected to dominate the market during the forecast period.

Facts and Factors published the latest report titled "Cardiovascular Devices Market Size, Share, Growth Analysis Report By Device Type (Therapeutic & Surgical Devices And Diagnostic & Monitoring Devices), By End users (Specialty Clinics And Hospitals), By Applications (Heart Failure, Cardiac Arrhythmia, And Coronary Artery Disease), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2023 - 2030" into their research database.

Industry Dynamics:

Global Cardiovascular Devices Market: Growth Drivers

  • The rising prevalence of cardiovascular diseases is likely to drive the growth of the global market.

The surging occurrences of heart diseases like coronary artery diseases (CAD) and heart failure are one of the major factors boosting the growth of the global cardiovascular devices market. These diseases are boosting the number of surgical operations, and increasing the need for cardiovascular devices.

Also, these heart problems require advanced cardiovascular devices. Some of the most used cardiovascular medical devices include coronary or cardiac stents. For instance, cardiovascular disease is known to be the primary cause of death per year. As per the stats from WHO, each year it is estimated to take around 17.9 million lives.

Another growth factor in the global cardiovascular devices market is the growing geriatric population worldwide. Aging causes malfunctioning in the heart and blood vessels which spike the risk of these cardiovascular diseases.

Global Cardiovascular Devices Market: Restraints

  • The high cost of cardiovascular procedures and devices is likely to impede the growth of the global market.

The cost of cardiovascular surgical procedures is very high due to the associated surgical complications. Additionally, such complicated surgeries require advanced and precise medical devices, making the process expensive. Therefore, it is not easily accessible to a wide population which is likely to impede the growth of the global cardiovascular devices industry during the forecast period.

Directly Purchase a Copy of the Report @ https://www.fnfresearch.com/buynow/su/cardiovascular-devices-market

Cardiovascular Devices Market: Opportunities

  • Growing focus on disease diagnostics is likely to offer new opportunities in the global market.

The demand for early diagnosis is increasing owing to the growing burden of cardiovascular diseases. People are now looking forward to taking advanced measures and precautions to save lives and avoid being at a serious stage. However, such advanced diagnosis requires the development of sophisticated and precise medical devices.

Therefore, the growing requirement for such advanced diagnostic cardiovascular devices is expected to create several new lucrative growth opportunities in the global cardiovascular devices market.

Cardiovascular Devices Market: Challenges

  • Reduction in hospital visits after covid-19 is likely to be the major challenge in the global market.

The advent of Covid-19 has caused a major change in the healthcare sector. People are not willing to visit hospitals for smaller problems. However, it has reduced the hospital's patient pool, which is expected to be a huge challenge in the global cardiovascular devices industry.

Global Cardiovascular Devices Market: Segmentation

  • The global cardiovascular devices market can be segmented into categories namely, device type, end users, applications, and region.

By device type, the market can be segmented into therapeutic & surgical devices and diagnostic & monitoring devices. The therapeutic & surgical devices segment can be further bifurcated into heart valves, stents, catheters, cardiac rhythm management devices, and ventricular assist devices. The diagnostic & monitoring devices segment can be further bifurcated into remote cardiac monitoring, electrocardiogram, and others. The diagnostic & monitoring devices segment is the fastest-growing segment in the global market.

By end-users, the market can be segmented into specialty clinics, hospitals, and others. The hospital segment accounts for the largest share of the global cardiovascular devices market.

By applications, the market can be segmented into heart failure, cardiac arrhythmia, and coronary artery disease. The heart failure segment is likely to dominate the global cardiovascular devices market.

Get More Insight before Buying@: https://www.fnfresearch.com/inquiry/cardiovascular-devices-market

List of Key Players in Cardiovascular Devices Market:

  • Boston Scientific Corporation
  • Medical Instruments Spa
  • LivaNova PLC
  • Lifetech Scientific
  • Getinge AB
  • CardioFocus
  • Occlutech
  • Stereotaxis Inc
  • CardioFocus
  • AngioDynamics Inc
  • Japan Lifeline Co. Ltd.
  • Medtronic
  • Biosense Webster
  • MicroPort Scientific Corporation
  • Abbott Laboratories
  • Lepu Medical Technology(Beijing)Co Ltd
  • Saphena Medical
  • Terumo Corporation
  • Biotronik SE & Co KG

Key questions answered in this report:

  • What are the growth rate forecast and market size for Cardiovascular Devices Market?
  • What are the key driving factors propelling the Cardiovascular Devices Market forward?
  • What are the most important companies in the Cardiovascular Devices Market Industry?
  • What segments does the Cardiovascular Devices Market cover?
  • How can I receive a free copy of the Cardiovascular Devices Market sample report and company profiles?

Report Scope:

Report Attribute

Details

Market size value in 2022

USD 5.8 Billion

Revenue forecast in 2030

USD 20.34 Billion

Growth Rate

CAGR of almost 13% 2023-2030

Base Year

2022

Historic Years

2016 - 2021

Forecast Years

2023-2030

Segments Covered

By Device Type, End users, Applications, and Region

Forecast Units

Value (USD Billion), and Volume (Units)

Quantitative Units

Revenue in USD million/billion and CAGR from 2023 to 2030

Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World

Countries Covered

U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others

Companies Covered

Boston Scientific Corporation, Medical Instruments Spa, LivaNova PLC, Lifetech Scientific, Getinge AB, CardioFocus, Occlutech, Stereotaxis Inc, CardioFocus, AngioDynamics Inc, Japan Lifeline Co. Ltd., Medtronic, Biosense Webster, MicroPort Scientific Corporation, Abbott Laboratories, Lepu Medical Technology(Beijing)Co Ltd, Saphena Medical, Terumo Corporation, Biotronik SE & Co KG, and others.

Report Coverage

Market growth drivers, restraints, opportunities, Porter's five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.

Customization Scope

Avail of customized purchase options to meet your exact research needs.

https://www.fnfresearch.com/customization/cardiovascular-devices-market

Free Brochure: https://www.fnfresearch.com/ask-to-analyst/cardiovascular-devices-market

Regional Dominance:

  • Asia Pacific to dominate the global market.

Asia Pacific is likely to register the highest growth rate in the global cardiovascular devices market during the forecast period due to the growing number of cardiovascular diseases in the region and the increasing geriatric population. Also, the growing disposable income of the people is another reason for the growth of the regional market. The development in technology and increase in research and development activities is also likely to support the growth of the regional market in the coming years.

However, Europe holds the second position to be the leading region in the global market due to the growing investments in the region. Also, the growing technological advancements in the region are likely to support the growth of the regional market.

Global Cardiovascular Devices Market is segmented as follows:

Cardiovascular Devices Market: By Device Type Outlook (2023-2030)

  • Therapeutic & Surgical Devices
  • Diagnostic & Monitoring Devices

Cardiovascular Devices Market: By End users Outlook (2023-2030)

  • Specialty Clinics
  • Hospitals

Cardiovascular Devices Market: By Applications Outlook (2023-2030)

  • Heart Failure
  • Cardiac Arrhythmia
  • Coronary Artery Disease

Cardiovascular Devices Market: By Region Outlook (2023-2030)

North America

  • The U.S.
  • Canada

Europe

  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Rest of Middle East & Africa

Press Release: https://www.fnfresearch.com/news/global-cardiovascular-devices-market

Browse Other Related Research Reports from Facts and Factors

  • Laboratory Glassware and Plasticware Market: According to the report published by Facts Factors, the global laboratory glassware and plasticware market size was worth around USD 6.12 billion in 2021 and is predicted to grow to around USD 7.52 billion by 2030 with a compound annual growth rate (CAGR) of roughly 3.45% between 2022 and 2030.
  • Endoscopic Retrograde Cholangiopancreatography (ERCP) Market: According to the report published by Facts Factors, the global Endoscopic Retrograde Cholangiopancreatography (ERCP) market size was worth around USD 1.4 billion in 2021 and is predicted to grow to around USD 2.5 billion by 2028 with a compound annual growth rate (CAGR) of roughly 8.5% between 2022 and 2028.
  • Self Contained Breathing Apparatus (SCBA) Market: According to Facts and Factors, the global oxygen concentrators market size was worth USD 1,629.30 million in 2021 and is estimated to grow to USD 2,542.70 million by 2028, with a compound annual growth rate (CAGR) of approximately 7.70% over the forecast period.
  • Oxygen Concentrators Market: According to the report published by Facts Factors, the global marine battery market size was worth around USD 0.53 billion in 2022 and is predicted to grow to around USD 2.1 billion by 2030 with a compound annual growth rate (CAGR) of roughly 18.61% between 2023 and 2030.
  • Cardiac Rhythm Management Devices Market: According to Facts and Factors, the Global Cardiac Rhythm Management Devices Market size was valued at USD 17,274.6 million in 2021 and is predicted to increase at a CAGR of 6.3% to USD 24,071.19 million by 2028.

Browse through Facts and Factors's coverage of the Global Medical Device Industry

Follow Us on: LinkedIn | Twitter | Facebook

About Us

Facts and Factors is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, and company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us-after all-if you do well, a little of the light shines on us.

Contact Us:

Facts and Factors
Tel: +1 347 690-0211
USA/Canada Toll-Free No. +44 2032 894158
Email: sales@fnfresearch.com
Website: https://www.fnfresearch.com/

Logo: https://mma.prnewswire.com/media/1981423/FnF_Research_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/usd-20-34-billion-growth-in-cardiovascular-devices-market-size---industry-analysis-market-trends-market-growth-opportunities-comprehensive-research-report-2023-2030-301827203.html

© 2023 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.